Fisher TS - Search Results

1

Ku: a multifunctional protein involved in telomere maintenance.

Fisher TS, Zakian VA. Fisher TS, et al. DNA Repair (Amst). 2005 Nov 21;4(11):1215-26. doi: 10.1016/j.dnarep.2005.04.021. Epub 2005 Jun 24. DNA Repair (Amst). 2005. PMID: 15979949 Review.

2

Cell cycle-dependent regulation of yeast telomerase by Ku.

Fisher TS, Taggart AK, Zakian VA. Fisher TS, et al. Nat Struct Mol Biol. 2004 Dec;11(12):1198-205. doi: 10.1038/nsmb854. Epub 2004 Nov 7. Nat Struct Mol Biol. 2004. PMID: 15531893

3

A flexible protein linker improves the function of epitope-tagged proteins in Saccharomyces cerevisiae.

Sabourin M, Tuzon CT, Fisher TS, Zakian VA. Sabourin M, et al. Among authors: fisher ts. Yeast. 2007 Jan;24(1):39-45. doi: 10.1002/yea.1431. Yeast. 2007. PMID: 17192851 Free PMC article.

4

The TATA-binding protein and associated factors are components of pol III transcription factor TFIIIB.

Taggart AK, Fisher TS, Pugh BF. Taggart AK, et al. Among authors: fisher ts. Cell. 1992 Dec 11;71(6):1015-28. doi: 10.1016/0092-8674(92)90396-t. Cell. 1992. PMID: 1458533

5

Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.

Yvan-Charvet L, Kling J, Pagler T, Li H, Hubbard B, Fisher T, Sparrow CP, Taggart AK, Tall AR. Yvan-Charvet L, et al. Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1430-8. doi: 10.1161/ATVBAHA.110.207142. Epub 2010 May 6. Arterioscler Thromb Vasc Biol. 2010. PMID: 20448206 Free PMC article.

6

On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.

Johns DG, Duffy J, Fisher T, Hubbard BK, Forrest MJ. Johns DG, et al. Drugs. 2012 Mar 5;72(4):491-507. doi: 10.2165/11599310-000000000-00000. Drugs. 2012. PMID: 22356288 Review.

7

Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice.

Chen Z, O'Neill EA, Meurer RD, Gagen K, Luell S, Wang SP, Ichetovkin M, Frantz-Wattley B, Eveland S, Strack AM, Fisher TS, Johns DG, Sparrow CP, Wright SD, Hubbard BK, Carballo-Jane E. Chen Z, et al. Among authors: fisher ts. J Cardiovasc Pharmacol Ther. 2012 Sep;17(3):315-23. doi: 10.1177/1074248411426144. Epub 2011 Nov 8. J Cardiovasc Pharmacol Ther. 2012. PMID: 22067613

8

Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation.

Fisher TS, Lo Surdo P, Pandit S, Mattu M, Santoro JC, Wisniewski D, Cummings RT, Calzetta A, Cubbon RM, Fischer PA, Tarachandani A, De Francesco R, Wright SD, Sparrow CP, Carfi A, Sitlani A. Fisher TS, et al. J Biol Chem. 2007 Jul 13;282(28):20502-12. doi: 10.1074/jbc.M701634200. Epub 2007 May 10. J Biol Chem. 2007. PMID: 17493938 Free article.

9

PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain.

Liu M, Wu G, Baysarowich J, Kavana M, Addona GH, Bierilo KK, Mudgett JS, Pavlovic G, Sitlani A, Renger JJ, Hubbard BK, Fisher TS, Zerbinatti CV. Liu M, et al. Among authors: fisher ts. J Lipid Res. 2010 Sep;51(9):2611-8. doi: 10.1194/jlr.M006635. Epub 2010 May 7. J Lipid Res. 2010. PMID: 20453200 Free PMC article.

10

Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein.

Han S, Levoci L, Fischer P, Wang SP, Gagen K, Chen Y, Xie D, Fisher T, Ehrhardt AG, Peier AM, Johns DG. Han S, et al. Biochim Biophys Acta. 2013 Apr;1831(4):825-33. doi: 10.1016/j.bbalip.2012.12.008. Epub 2012 Dec 23. Biochim Biophys Acta. 2013. PMID: 23269286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page